Correlation Between Eterna Therapeutics and Oragenics
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Oragenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Oragenics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Oragenics, you can compare the effects of market volatilities on Eterna Therapeutics and Oragenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Oragenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Oragenics.
Diversification Opportunities for Eterna Therapeutics and Oragenics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eterna and Oragenics is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Oragenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oragenics and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Oragenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oragenics has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Oragenics go up and down completely randomly.
Pair Corralation between Eterna Therapeutics and Oragenics
Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Oragenics. In addition to that, Eterna Therapeutics is 1.65 times more volatile than Oragenics. It trades about -0.56 of its total potential returns per unit of risk. Oragenics is currently generating about -0.01 per unit of volatility. If you would invest 37.00 in Oragenics on September 12, 2024 and sell it today you would lose (1.42) from holding Oragenics or give up 3.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eterna Therapeutics vs. Oragenics
Performance |
| Timeline |
| Eterna Therapeutics |
| Oragenics |
Eterna Therapeutics and Oragenics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eterna Therapeutics and Oragenics
The main advantage of trading using opposite Eterna Therapeutics and Oragenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Oragenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will offset losses from the drop in Oragenics' long position.| Eterna Therapeutics vs. Equillium | Eterna Therapeutics vs. DiaMedica Therapeutics | Eterna Therapeutics vs. Valneva SE ADR | Eterna Therapeutics vs. Vivani Medical |
| Oragenics vs. Equillium | Oragenics vs. DiaMedica Therapeutics | Oragenics vs. Valneva SE ADR | Oragenics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |